Supplementary Fig. 28.: Characterization of haemathrin-2 (1–59)—Dep. Research Chemistry, Novo Nordisk.

a) Analytical reverse-phase HPLC trace (C18 CSH) and b) ESI mass envelope of reverse-phase HPLC purified Haemathrin-2 Rt 1.78 min (5% B over 0.5 min followed by 5 to 60% B over 3.5 min, λ = 214 nm); Calculated Mass [M+4H]⁴⁺: 1678.1, [M+5H]⁵⁺: 1342.7, [M+6H]⁶⁺: 1119.0, [M+7H]⁷⁺: 959.3, [M+8H]⁸⁺: 839.5, [M+9H]⁹⁺: 746.4, [M+10H]¹⁰⁺: 671.8; Mass Found (ESI+): 1677.9 [M+4H]⁴⁺, 1342.5 [M+5H]⁵⁺, 1119.0 [M+6H]⁶⁺, 959.3 [M+7H]⁷⁺, 839.5 [M+8H]⁸⁺, 746.3 [M+9H]⁹⁺, 671.8 [M+10H]¹⁰⁺.